Drugs Made In America Acquisition II Corp. Right (DMIIR) Stock
Financial Services · Asset Management · US
$0.06
-25.88%
Last updated Jun 18, 2026 23:50 UTC
DMIIR Key Statistics
Market Cap$4.01M
P/E (TTM)-21.72
P/S (TTM)—
P/B (TTM)0.01
Revenue (TTM)$0.00
EPS (TTM)$0.00
Dividend Yield—
ROE (TTM)-0.09%
Net Margin0.00%
Gross Margin0.00%
52W High$0.13
52W Low$0.06
Analyst View—
Price Target—
Employees—
Volume1
About Drugs Made In America Acquisition II Corp. Right
Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.
CEO: Roger Bendelac. Company website
See DMIIR live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open DMIIR in Terminal See plans